Literature DB >> 26916278

The role of mutations in the SCN5A gene in cardiomyopathies.

Elena Zaklyazminskaya1, Sergei Dzemeshkevich2.   

Abstract

The SCN5A gene encodes the alpha-subunit of the Nav1.5 ion channel protein, which is responsible for the sodium inward current (INa). Since 1995 several hundred mutations in this gene have been found to be causative for inherited arrhythmias including Long QT syndrome, Brugada syndrome, cardiac conduction disease, sudden infant death syndrome, etc. As expected these syndromes are primarily electrical heart diseases leading to life-threatening arrhythmias with an "apparently normal heart". In 2003 a new form of dilated cardiomyopathy was identified associated with mutations in the SCN5A gene. Recently mutations have been also found in patients with arrhythmogenic right ventricular cardiomyopathy and atrial standstill. The purpose of this review is to outline and analyze the following four topics: 1) SCN5A genetic variants linked to different cardiomyopathies; 2) clinical manifestations of the known mutations; 3) possible molecular mechanisms of myocardial remodeling; and 4) the potential implications of gene-specific treatment for those disorders. This article is part of a Special Issue entitled: Cardiomyocyte Biology: Integration of Developmental and Environmental Cues in the Heart edited by Marcus Schaub and Hughes Abriel.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arrhythmogenic right ventricular cardiomyopathy; Cardiac remodeling; Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Na(v)1.5; SCN5A

Mesh:

Substances:

Year:  2016        PMID: 26916278     DOI: 10.1016/j.bbamcr.2016.02.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  Myriad roles of voltage-activated potassium channel subunit Kvβ1.1 in the heart.

Authors:  Rakesh C Kukreja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-27       Impact factor: 4.733

Review 2.  Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Authors:  Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

3.  Targeted molecular genetic testing in young sudden cardiac death victims from Western Denmark.

Authors:  Maiken Kudahl Larsen; Sofie Lindgren Christiansen; Christin Løth Hertz; Rune Frank-Hansen; Henrik Kjærulf Jensen; Jytte Banner; Niels Morling
Journal:  Int J Legal Med       Date:  2019-11-15       Impact factor: 2.686

Review 4.  Inhibition of NaV1.7: the possibility of ideal analgesics.

Authors:  Yutaka Kitano; Tsuyoshi Shinozuka
Journal:  RSC Med Chem       Date:  2022-08-01

Review 5.  How Functional Genomics Can Keep Pace With VUS Identification.

Authors:  Corey L Anderson; Saba Munawar; Louise Reilly; Timothy J Kamp; Craig T January; Brian P Delisle; Lee L Eckhardt
Journal:  Front Cardiovasc Med       Date:  2022-07-04

Review 6.  Genetics of Dilated Cardiomyopathy.

Authors:  Yiwen Fu; Howard J Eisen
Journal:  Curr Cardiol Rep       Date:  2018-09-27       Impact factor: 2.931

7.  Rapid and effective response of the R222Q SCN5A to quinidine treatment in a patient with Purkinje-related ventricular arrhythmia and familial dilated cardiomyopathy: a case report.

Authors:  Joanna Zakrzewska-Koperska; Maria Franaszczyk; Zofia Bilińska; Grażyna Truszkowska; Małgorzata Karczmarz; Łukasz Szumowski; Tomasz Zieliński; Rafał Płoski; Maria Bilińska
Journal:  BMC Med Genet       Date:  2018-06-05       Impact factor: 2.103

Review 8.  Emerging concepts in arrhythmogenic dilated cardiomyopathy.

Authors:  Thomas Zegkos; Theofilos Panagiotidis; Despoina Parcharidou; Georgios Efthimiadis
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

9.  In vivo Dominant-Negative Effect of an SCN5A Brugada Syndrome Variant.

Authors:  Nicolas Doisne; Marta Grauso; Nathalie Mougenot; Michel Clergue; Charlotte Souil; Alain Coulombe; Pascale Guicheney; Nathalie Neyroud
Journal:  Front Physiol       Date:  2021-05-28       Impact factor: 4.566

10.  Life-Threatening Ventricular Arrhythmia Induced by Atrial Tachycardia in a Child with an SCN5A Mutation.

Authors:  Márcio Augusto Silva; Jorge Elias Neto; Guilherme Muller de Campos Futuro; Erick Sessa Merçon; Deborah Vasconcelos; Ricardo Kuniyoshi
Journal:  Arq Bras Cardiol       Date:  2021-07       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.